TY - JOUR
T1 - Successful implantation of a second-generation aortic valve in severe aortic regurgitation secondary to a traumatic cusp lesion
AU - Mangieri, Antonio
AU - Latib, Azeem
AU - Aurelio, Andrea
AU - Figini, Filippo
AU - Agricola, Eustachio
AU - Rosa, Isabella
AU - Stella, Stefano
AU - Spagnolo, Pietro
AU - Castiglioni, Alessandro
AU - Colombo, Antonio
N1 - Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/10
Y1 - 2015/10
N2 - A 67-year-old man with a dilated cardiomyopathy and severe aortic regurgitation (AR) secondary to a traumatic cusp lesion was referred to our institution because of progressive worsening of dyspnea. After formal discussion in the heart team, the patient was scheduled for TAVI (transcatheter aortic valve implantation). The pre procedural computed tomography scan revealed a minimum amount of calcium on the aortic valve and low position of coronary ostia. The TAVI procedure was performed with the implantation of a fully retrievable and repositionable aortic valve prosthesis (Direct Flow 29 mm, Direct Flow Medical, Santa Rosa, California) with an excellent result and no paravalvular leak. The TAVI devices designed for the treatment of calcific aortic stenosis have numerous limitations for the treatment of pure AR such as the risk of residual AR, the lack of repositionability and retrievability, and the need for valve- in-valve implantation. We believe that treatment of selected cases of pure AR with the Direct Flow valve is feasible and takes advantage of the retrievability of the prosthesis.
AB - A 67-year-old man with a dilated cardiomyopathy and severe aortic regurgitation (AR) secondary to a traumatic cusp lesion was referred to our institution because of progressive worsening of dyspnea. After formal discussion in the heart team, the patient was scheduled for TAVI (transcatheter aortic valve implantation). The pre procedural computed tomography scan revealed a minimum amount of calcium on the aortic valve and low position of coronary ostia. The TAVI procedure was performed with the implantation of a fully retrievable and repositionable aortic valve prosthesis (Direct Flow 29 mm, Direct Flow Medical, Santa Rosa, California) with an excellent result and no paravalvular leak. The TAVI devices designed for the treatment of calcific aortic stenosis have numerous limitations for the treatment of pure AR such as the risk of residual AR, the lack of repositionability and retrievability, and the need for valve- in-valve implantation. We believe that treatment of selected cases of pure AR with the Direct Flow valve is feasible and takes advantage of the retrievability of the prosthesis.
KW - Aortic regurgitation
KW - Transcatheter aortic valve replacement
UR - http://www.scopus.com/inward/record.url?scp=84948107785&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84948107785&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2015.04.007
DO - 10.1016/j.carrev.2015.04.007
M3 - Article
C2 - 26070636
AN - SCOPUS:84948107785
SN - 1553-8389
VL - 16
SP - 429
EP - 431
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
IS - 7
ER -